tiprankstipranks
Trending News
More News >
Therapeutic Solutions International Inc (TSOI)
OTHER OTC:TSOI
US Market

Therapeutic Solutions International (TSOI) Ratios

Compare
66 Followers

Therapeutic Solutions International Ratios

TSOI's free cash flow for Q3 2024 was $0.78. For the 2024 fiscal year, TSOI's free cash flow was decreased by $ and operating cash flow was $-98.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
0.05 0.05 0.14 0.45 0.15
Quick Ratio
0.03 0.03 0.12 0.43 0.15
Cash Ratio
0.01 0.01 <0.01 0.04 0.11
Solvency Ratio
-0.92 -0.92 -1.61 -1.17 -0.92
Operating Cash Flow Ratio
-0.56 -0.56 -0.46 -0.29 -0.28
Short-Term Operating Cash Flow Coverage
-1.39 -1.39 -0.96 -0.69 -0.68
Net Current Asset Value
$ -1.92M$ -1.92M$ -1.91M$ -1.40M$ -2.03M
Leverage Ratios
Debt-to-Assets Ratio
0.27 0.27 0.30 0.64 1.72
Debt-to-Equity Ratio
0.79 0.79 0.88 -1.36 -0.59
Debt-to-Capital Ratio
0.44 0.44 0.47 3.75 -1.41
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 <0.01 -0.02 0.00
Financial Leverage Ratio
2.93 2.93 2.95 -2.13 -0.34
Debt Service Coverage Ratio
-1.26 -1.26 -1.75 -1.40 -1.47
Interest Coverage Ratio
-4.69 -4.69 -5.08 -3.77 -6.11
Debt to Market Cap
1.49 0.24 0.07 0.02 0.08
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
-0.58 -0.58 -0.35 -0.43 -0.42
Profitability Margins
Gross Profit Margin
62.86%62.86%61.58%70.85%79.59%
EBIT Margin
-1817.47%-1817.47%-1562.32%-1609.29%-3027.11%
EBITDA Margin
-1502.53%-1502.53%-1444.01%-1596.91%-3015.97%
Operating Profit Margin
-2006.67%-2006.67%-1586.03%-1578.79%-2950.78%
Pretax Profit Margin
-2245.04%-2245.04%-1874.80%-2028.45%-3509.68%
Net Profit Margin
-2191.86%-2191.86%-1844.58%-2029.00%-3509.68%
Continuous Operations Profit Margin
-2247.31%-2247.31%-1875.57%-2029.00%-3509.68%
Net Income Per EBT
97.63%97.63%98.39%100.03%100.00%
EBT Per EBIT
111.88%111.88%118.21%128.48%118.94%
Return on Assets (ROA)
-65.91%-65.91%-105.78%-172.60%-364.54%
Return on Equity (ROE)
-184.90%-192.82%-312.18%367.89%123.72%
Return on Capital Employed (ROCE)
-142.66%-142.66%-235.03%295.19%106.06%
Return on Invested Capital (ROIC)
-91.55%-91.55%-133.18%-785.89%250.73%
Return on Tangible Assets
-367.80%-367.80%-632.95%-186.64%-475.03%
Earnings Yield
-684.72%-68.47%-25.14%-4.51%-17.87%
Efficiency Ratios
Receivables Turnover
5.16 5.16 8.14 8.79 25.68
Payables Turnover
0.09 0.09 0.19 0.11 0.04
Inventory Turnover
1.63 1.63 1.87 1.07 2.37
Fixed Asset Turnover
0.20 0.20 0.73 0.46 0.98
Asset Turnover
0.03 0.03 0.06 0.09 0.10
Working Capital Turnover Ratio
-0.05 -0.05 -0.13 -0.09 -0.03
Cash Conversion Cycle
-3.72K -3.72K -1.64K -3.08K -8.67K
Days of Sales Outstanding
70.78 70.78 44.83 41.55 14.21
Days of Inventory Outstanding
224.09 224.09 194.94 341.60 154.05
Days of Payables Outstanding
4.02K 4.02K 1.88K 3.46K 8.84K
Operating Cycle
294.87 294.87 239.78 383.15 168.27
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
<0.01 <0.01 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.02 1.02 1.00 1.36 1.01
Dividend Paid and CapEx Coverage Ratio
-65.31 -65.31 0.00 -2.76 -121.71
Capital Expenditure Coverage Ratio
-65.31 -65.31 0.00 -2.76 -121.71
Operating Cash Flow Coverage Ratio
-1.19 -1.19 -0.94 -0.65 -0.64
Operating Cash Flow to Sales Ratio
-10.66 -10.66 -4.92 -4.93 -10.58
Free Cash Flow Yield
-209.16%-33.81%-6.71%-1.49%-5.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.15 -1.46 -3.98 -22.16 -5.60
Price-to-Sales (P/S) Ratio
5.17 32.01 73.36 449.66 196.43
Price-to-Book (P/B) Ratio
0.28 2.82 12.42 -81.53 -6.92
Price-to-Free Cash Flow (P/FCF) Ratio
-0.48 -2.96 -14.90 -67.01 -18.42
Price-to-Operating Cash Flow Ratio
-0.30 -3.00 -14.90 -91.29 -18.57
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.03 -0.26 -2.66 0.22
Price-to-Fair Value
0.28 2.82 12.42 -81.53 -6.92
Enterprise Value Multiple
-0.92 -2.71 -5.44 -28.59 -6.93
Enterprise Value
1.37M 4.03M 16.23M 66.63M 13.10M
EV to EBITDA
-0.92 -2.71 -5.44 -28.59 -6.93
EV to Sales
13.86 40.70 78.48 456.54 209.00
EV to Free Cash Flow
-1.28 -3.76 -15.94 -68.03 -19.60
EV to Operating Cash Flow
-1.30 -3.82 -15.94 -92.69 -19.76
Tangible Book Value Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Shareholders’ Equity Per Share
<0.01 <0.01 <0.01 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 >-0.01 0.00
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax Burden
0.98 0.98 0.98 1.00 1.00
Interest Burden
1.24 1.24 1.20 1.26 1.16
Research & Development to Revenue
5.66 5.66 6.97 5.45 8.97
SG&A to Revenue
10.65 10.65 8.54 11.05 21.34
Stock-Based Compensation to Revenue
4.00 4.00 7.95 9.17 18.60
Income Quality
0.49 0.49 0.28 0.24 0.30
Currency in USD